Arkolith/Insider Trading/ROIV/Form 4

Venker Eric

President & Immunovant CEORoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Jan 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.4M
Net Open-Market Flow
-$4.4M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 12, 2026Sell(S)200K$21.92$4.4M1.7M
Jan 12, 2026Option exercise(M)200K$3.85$770K1.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 12, 2026Option exercise(M)200K—$05.2M

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-001239) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML